B-D-Galactose

B-D-Galactose

SCHEMBL1712843

O=c1ccc2nc3ccccc3oc-2c1.OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SLC5A2 P31639 3/20 0.49
APP P05067 12/20 0.48
CYP1A2 P05177 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
ALPL P05186 1/20 0.43
POLB P06746 1/20 0.43
ALPI P09923 1/20 0.43
MAPT P10636 1/20 0.43
ALPG P10696 1/20 0.43
RECQL P46063 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Beta-D-Glucose SCHEMBL383291 1.00 SLC5A2 (0.49) SLC5A2APPCYP1A2KDM4EMEN1
Dextrose SCHEMBL5679244 1.00 SLC5A2 (0.49) SLC5A2APPCYP1A2KDM4EMEN1
B-D-Galactose SCHEMBL8515088 1.00 SLC5A2 (0.49) SLC5A2APPCYP1A2KDM4EMEN1
D-Galactose SCHEMBL2370315 1.00 SLC5A2 (0.49) SLC5A2APPCYP1A2KDM4EMEN1
B-D-Galactose SCHEMBL307802 1.00 SLC5A2 (0.49) SLC5A2APPCYP1A2KDM4EMEN1
Beta-D-Glucose SCHEMBL3018938 0.87 APP (0.68) APPCYP1A2KDM4EMEN1ALDH1A1
D-Galactose SCHEMBL15391861 0.87 APP (0.68) APPCYP1A2KDM4EMEN1ALDH1A1
B-D-Galactose SCHEMBL307801 0.87 APP (0.68) APPCYP1A2KDM4EMEN1ALDH1A1
N-Acetylglucosamine SCHEMBL5692330 0.86 HK1 (0.43) SLC5A2APPCYP1A2POLB
SCHEMBL3827094 0.85 APP (0.49) SLC5A2APPCYP1A2KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344663-B1 REACTION MEDIUM FOR STAPHYLOCOCCUS AUREUS BACTERIA BIOMERIEUX SA (FR) 2015-12-23 EP disclosed
US-8741597-B2 Reaction medium for methicillin-resistant Staphylococcus aureus bioMérieux (FR) 2014-06-03 US disclosed
WO-2012061597-A1 ALPHA-GLUCOSIDASE BINDERS AND METHODS OF THEIR USE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH (US) 2012-05-10 WO disclosed
EP-2344663-A2 REACTION MEDIUM FOR STAPHYLOCOCCUS AUREUS BACTERIA Biomérieux (FR) 2011-07-20 EP disclosed
US-20110165614-A1 REACTION MEDIUM FOR STAPHYLOCOCCUS AUREUS BACTERIA BIOMERIEUX (FR) 2011-07-07 US disclosed
WO-2010040952-A2 REACTION MEDIUM FOR STAPHYLOCOCCUS AUREUS BACTERIA bioMérieux (FR) 2010-04-15 WO disclosed
US-5473058-A A maltooligosaccharide attached to a dye, preferably resorufin or a halonitro phenol; a substrate in the presence of salivary alpha-amylase BOEHRINGER MANNHEIM GMBH (DE) 1995-12-05 US disclosed
EP-0157384-B1 Substrates for hydrolases, process for their preparation and their use BIOMED LABORDIAGNOSTIK GMBH (DE) 1995-01-18 EP disclosed
US-5264345-A Process and reagent for the specific determination of pancreatic a-amylase BOEHRINGER MANNHEIM GMBH (DE) 1993-11-23 US disclosed
US-4716222-A CHROMOGENS, SPECTROPHOTOMETRY HOECHST AKTIENGESELLSCHAFT (DE) 1987-12-29 US disclosed
EP-0157384-A2 Substrates for hydrolases, process for their preparation and their use Biomed Labordiagnostik GmbH (DE) 1985-10-09 EP disclosed